Sílvia Coma

1.6k total citations
38 papers, 857 citations indexed

About

Sílvia Coma is a scholar working on Molecular Biology, Oncology and Pathology and Forensic Medicine. According to data from OpenAlex, Sílvia Coma has authored 38 papers receiving a total of 857 indexed citations (citations by other indexed papers that have themselves been cited), including 20 papers in Molecular Biology, 15 papers in Oncology and 8 papers in Pathology and Forensic Medicine. Recurrent topics in Sílvia Coma's work include Melanoma and MAPK Pathways (7 papers), Chronic Lymphocytic Leukemia Research (5 papers) and Cancer Mechanisms and Therapy (5 papers). Sílvia Coma is often cited by papers focused on Melanoma and MAPK Pathways (7 papers), Chronic Lymphocytic Leukemia Research (5 papers) and Cancer Mechanisms and Therapy (5 papers). Sílvia Coma collaborates with scholars based in United States, Spain and Italy. Sílvia Coma's co-authors include Michael Klagsbrun, Akio Shimizu, Jonathan A. Pachter, Hironao Nakayama, Tomoshige Akino, Akiko Mammoto, Valerie L. Luks, Carlos J. Ciudad, Verónique Noé and Joyce Bischoff and has published in prestigious journals such as Journal of Biological Chemistry, The Journal of Experimental Medicine and Blood.

In The Last Decade

Sílvia Coma

35 papers receiving 845 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Sílvia Coma United States 13 489 276 162 141 111 38 857
Huibin Yang United States 16 622 1.3× 316 1.1× 233 1.4× 141 1.0× 158 1.4× 22 1.0k
Ren Xu United States 17 483 1.0× 222 0.8× 105 0.6× 193 1.4× 129 1.2× 38 1.0k
María Teresa Calvo Spain 12 625 1.3× 235 0.9× 202 1.2× 78 0.6× 84 0.8× 17 1.0k
Michael Kluge Germany 18 482 1.0× 240 0.9× 274 1.7× 122 0.9× 104 0.9× 34 1.0k
Susanne Kleber Germany 13 610 1.2× 207 0.8× 345 2.1× 137 1.0× 152 1.4× 15 1.1k
Silvia Truffa Italy 13 707 1.4× 269 1.0× 153 0.9× 82 0.6× 182 1.6× 15 1.1k
Agata Zieba Sweden 16 520 1.1× 192 0.7× 96 0.6× 59 0.4× 116 1.0× 22 922
Qiqun Zeng China 9 556 1.1× 301 1.1× 151 0.9× 108 0.8× 178 1.6× 9 986
Gal Akiri United States 12 1.0k 2.0× 296 1.1× 139 0.9× 105 0.7× 245 2.2× 15 1.4k
Kara White Moyes United States 12 416 0.9× 387 1.4× 220 1.4× 55 0.4× 164 1.5× 17 924

Countries citing papers authored by Sílvia Coma

Since Specialization
Citations

This map shows the geographic impact of Sílvia Coma's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Sílvia Coma with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Sílvia Coma more than expected).

Fields of papers citing papers by Sílvia Coma

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Sílvia Coma. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Sílvia Coma. The network helps show where Sílvia Coma may publish in the future.

Co-authorship network of co-authors of Sílvia Coma

This figure shows the co-authorship network connecting the top 25 collaborators of Sílvia Coma. A scholar is included among the top collaborators of Sílvia Coma based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Sílvia Coma. Sílvia Coma is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Kircher, David A., et al.. (2025). Combined inhibition of focal adhesion kinase and RAF/MEK elicits synergistic inhibition of melanoma growth and reduces metastases. Cell Reports Medicine. 6(2). 101943–101943. 2 indexed citations
2.
Hartwich, Tobias M.P., Stefania Bellone, Shuvro P. Nandi, et al.. (2024). Preclinical evaluation of avutometinib and defactinib in high‐grade endometrioid endometrial cancer. Cancer Medicine. 13(17). e70210–e70210. 5 indexed citations
3.
McNamara, Blair, Tobias M.P. Hartwich, Diego Manavella, et al.. (2024). Preclinical efficacy of RAF/MEK clamp avutometinib in combination with FAK inhibition in low grade serous ovarian cancer. Gynecologic Oncology. 183. 133–140. 11 indexed citations
4.
Till, Kathleen J., Thomas A. Marks, Sílvia Coma, et al.. (2023). Roles of PI3Kγ and PI3Kδ in mantle cell lymphoma proliferation and migration contributing to efficacy of the PI3Kγ/δ inhibitor duvelisib. Scientific Reports. 13(1). 3793–3793. 5 indexed citations
5.
Sharma, Aditi, Vikas A. Gupta, Shanmuganathan Chandrakasan, et al.. (2022). PI3Kδ/γ inhibition promotes human CART cell epigenetic and metabolic reprogramming to enhance antitumor cytotoxicity. Blood. 139(4). 523–537. 91 indexed citations
6.
McGovern, Karen, Alfredo Castro, Jill Cavanaugh, et al.. (2022). Discovery and Characterization of a Novel Aryl Hydrocarbon Receptor Inhibitor, IK-175, and Its Inhibitory Activity on Tumor Immune Suppression. Molecular Cancer Therapeutics. 21(8). 1261–1272. 27 indexed citations
7.
Paradis, Justine S., Robert Saddawi‐Konefka, Simone Lubrano, et al.. (2021). Synthetic Lethal Screens Reveal Cotargeting FAK and MEK as a Multimodal Precision Therapy for GNAQ -Driven Uveal Melanoma. Clinical Cancer Research. 27(11). 3190–3200. 54 indexed citations
8.
Godfrey, James, Wenjun Kang, Lei Huang, et al.. (2020). Macrophage Activation By Dual PI3K-δ/γ Inhibition Enhances Anti-CD47-Mediated Phagocytosis and Prolongs Survival in DLBCL. Blood. 136(Supplement 1). 40–40. 4 indexed citations
9.
Coma, Sílvia, David T. Weaver, & Jonathan A. Pachter. (2020). Abstract 663: The dual PI3K-δ/PI3K-γ inhibitor duvelisib inhibits signaling and proliferation of solid tumor cells expressing PI3K-δ and/or PI3K-γ. Cancer Research. 80(16_Supplement). 663–663. 1 indexed citations
10.
Coma, Sílvia, et al.. (2020). Abstract CT045: Synergistic anti-tumor efficacy of the dual PI3K-δ/PI3K-γ inhibitor duvelisib with PD-1 blockade in solid tumor and lymphoma models. Cancer Research. 80(16_Supplement). CT045–CT045. 2 indexed citations
11.
Coma, Sílvia, Jill Cavanaugh, James Nolan, et al.. (2018). Abstract 3757: Targeting the IDO/TDO pathway through degradation of the immunosuppressive metabolite kynurenine. Cancer Research. 78(13_Supplement). 3757–3757. 1 indexed citations
12.
13.
Wang, Leo, Sílvia Coma, Areum Han, et al.. (2016). Developmental regulation of myeloerythroid progenitor function by the LIN28B-LET-7-HMGA2 axis. Experimental Hematology. 44(9). S50–S50. 6 indexed citations
14.
Nakayama, Hironao, et al.. (2015). Regulation of mTOR Signaling by Semaphorin 3F-Neuropilin 2 Interactions In Vitro and In Vivo. Scientific Reports. 5(1). 11789–11789. 45 indexed citations
15.
Boscolo, Elisa, Sílvia Coma, Valerie L. Luks, et al.. (2014). AKT hyper-phosphorylation associated with PI3K mutations in lymphatic endothelial cells from a patient with lymphatic malformation. Angiogenesis. 18(2). 151–162. 94 indexed citations
16.
Coma, Sílvia, et al.. (2013). GATA2 and Lmo2 control angiogenesis and lymphangiogenesis via direct transcriptional regulation of neuropilin-2. Angiogenesis. 16(4). 939–952. 40 indexed citations
17.
Shimizu, Akio, Hironao Nakayama, Courtney König, et al.. (2012). Netrin-1 Promotes Glioblastoma Cell Invasiveness and Angiogenesis by Multiple Pathways Including Activation of RhoA, Cathepsin B, and cAMP-response Element-binding Protein. Journal of Biological Chemistry. 288(4). 2210–2222. 87 indexed citations
18.
Coma, Sílvia, Akio Shimizu, & Michael Klagsbrun. (2011). Hypoxia induces tumor and endothelial cell migration in a Semaphorin 3F- and VEGF-dependent manner via transcriptional repression of their common receptor Neuropilin 2. Cell Adhesion & Migration. 5(3). 266–275. 49 indexed citations
19.
Coma, Sílvia, Dhara N. Amin, Akio Shimizu, et al.. (2010). Id2 Promotes Tumor Cell Migration and Invasion through Transcriptional Repression of Semaphorin 3F. Cancer Research. 70(9). 3823–3832. 70 indexed citations
20.
Coma, Sílvia, Verónique Noé, Cinzia Lavarino, et al.. (2004). Use of siRNAs and Antisense Oligonucleotides Against Survivin RNA to Inhibit Steps Leading to Tumor Angiogenesis. Oligonucleotides. 14(2). 100–113. 56 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Huibin Yang Breakdown of academic impact, for papers by Ren Xu Breakdown of academic impact, for papers by María Teresa Calvo Breakdown of academic impact, for papers by Michael Kluge Breakdown of academic impact, for papers by Susanne Kleber Breakdown of academic impact, for papers by Silvia Truffa Breakdown of academic impact, for papers by Agata Zieba Breakdown of academic impact, for papers by Qiqun Zeng Breakdown of academic impact, for papers by Gal Akiri Breakdown of academic impact, for papers by Kara White Moyes
Rankless by CCL
2026